Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis
This study is currently recruiting participants.
Verified January 2013 by Cubist Pharmaceuticals
Study NCT01345929
Information provided by Cubist Pharmaceuticals
First Received on April 28, 2011.
Last Updated on January 22, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
